Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
| Image |  |
|---|---|
| Description | scientific article published on 20 April 2020 |
| Author/s |
author: Amy Flaxman Eleanor Berrie Katie J. Ewer Sarah Gilbert Alison M. Lawrie Teresa Lambe |
| Publication date | April 20, 2020 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |